Skip to main content
. 2020 Sep 18;8:838. doi: 10.3389/fchem.2020.00838

Figure 15.

Figure 15

Schematic illustration of B-PDEA–mediated BDNF transfection of NSCs for ischemic stroke treatment (Jiang et al., 2019) (Copyright 2019, reproduced with permission from John Wiley and Sons). (i) B-PDEA complexes BDNF plasmids to form polyplexes used for transfection of NSCs. (ii) The transfected NSCs i.v. transplanted to MCAO mice migrate to the injured area in the brain, whose high level of ROS efficiently triggers B-PDEA's conversion to negatively charged polyacrylate and the release of BDNF plasmids for NSCs to express and excrete BDNF. The released BDNF stimulates nerve regeneration and functional reconstruction, giving rise to a significant therapeutic effect in ischemic stroke.